Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling
Haiyong Wang(Fudan University Shanghai Cancer Center), Zhiqiang Meng(Fudan University Shanghai Cancer Center)
Cited by 46
Related Papers
The serum miR‐21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR‐21 expression confers chemoresistance by targeting FasL
|Molecular Oncology|2012|184
Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients
|Oncotarget|2017|93
FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1
|Cell Communication and Signaling|2020|93
Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression
|Journal of Experimental & Clinical Cancer Research|2019|86
Bufalin enhances anti-angiogenic effect of sorafenib via AKT/VEGF signaling
|International Journal of Oncology|2016|42